Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Topotecan in Treating Patients With Recurrent Ovarian Epithelial or Primary Peritoneal Cancer

This study has been terminated.
National Cancer Institute (NCI)
Information provided by:
Gynecologic Oncology Group Identifier:
First received: April 6, 2000
Last updated: April 10, 2013
Last verified: July 2004
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: January 2004 (Final data collection date for primary outcome measure)